ArticleCancer chemotherapy and pharmacology2022

Starting dose selection of palbociclib in Chinese patients with breast cancer based on population kinetic-pharmacodynamic model of neutropenia.

Weizhe Jian et al.PubMed ↗Publisher ↗

No numbers read from the abstract.